Cargando…
Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors
Herein, we report an eco-friendly synthesis of a new series of quinazolinone-based derivatives as potential PARP-1 inhibitors. The 4-quinazolinone scaffold was utilized as a bioisostere to the phthalazinone core of the reference compound Olaparib. Most of the synthesized compounds displayed apprecia...
Autores principales: | Ramadan, Sayed K., Elrazaz, Eman Z., Abouzid, Khaled A. M., El-Naggar, Abeer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055986/ https://www.ncbi.nlm.nih.gov/pubmed/35521104 http://dx.doi.org/10.1039/d0ra05943a |
Ejemplares similares
-
Discovery of pyrano[2,3-d]pyrimidine-2,4-dione derivatives as novel PARP-1 inhibitors: design, synthesis and antitumor activity
por: Abd El-sattar, Nour E. A., et al.
Publicado: (2021) -
Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
por: Sonousi, Amr, et al.
Publicado: (2022) -
Fragment merging approach for design, synthesis, and biological assessment of urea/acetyl hydrazide clubbed thienopyrimidine derivatives as GSK-3β inhibitors
por: Saleh, Joseph S., et al.
Publicado: (2023) -
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
por: Le, Yi, et al.
Publicado: (2020) -
Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition
por: Noser, Ahmed A., et al.
Publicado: (2020)